title

Pharma Talk

John Mack

0
Followers
0
Plays
Pharma Talk

Pharma Talk

John Mack

0
Followers
0
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

Pharmaguy (aka John Mack) is a thought leader in pharmaceutical marketing with more than 30 years experience in the digital space, including interactive game design, computer-based learning, drug website development, ehealth ethics, and social media.

Latest Episodes

The Misleading Marketing of "Low-T" Drugs

A conversation with Adriane Fugh-Berman, MD, Associate Professor at Georgetown University Medical Center and Director of PharmedOut. We discuss how the marketing of Androgel uses symptom quizzes to convince men and physicians that "low testosterone" is a medical condition that should be treated. We also discuss the dangerous side effects of testosterone treatment and the similarities with estrogen treatment side effects, which took 20 years to unveil.

5 MIN2017 JUL 25
Comments
The Misleading Marketing of "Low-T" Drugs

The Forgotten eHealth Code of Ethics

Any research or effort designed to improve the quality of health information on the Internet must build upon the work already done by the creators of the international eHealth Code of Ethics, which is as relevant today as it was back in 2000.

4 MIN2017 JUN 23
Comments
The Forgotten eHealth Code of Ethics

AMA Struggles to Reign in Consumer Drug Ads

You have to give kudos to the good doctors and policy makers of the American Medical Association for trying over the course of many to ban or in some way curtail direct-to-consumer drug ads by pharmaceutical companies. The latest effort focuses on drug price transparency in ads. Will it succeed where the other efforts have failed?

4 MIN2017 JUN 16
Comments
AMA Struggles to Reign in Consumer Drug Ads

Counter Detailing Offers Redemption But Little Hope of Success

Do you hate your job in pharma? Perhaps, like a friend of mine, your position got eliminated after many years of loyal service. But it may be a blessing in disguise if the behavior of Big Pharma is more and more at odds with your personal values. If so, you have options for cleansing your soul.

4 MIN2017 JUN 13
Comments
Counter Detailing Offers Redemption But Little Hope of Success

Patient Centricity & Pharma’s Reputation

Patient Centricity used to be a buzzword in that it was often mentioned but seldom practiced by pharma companies. A lot of progress has been made in the past years to achieve patient centricity, but not all drug companies have had much success. Unfortunately, that has had a negative impact on the industry’s reputation

3 MIN2017 JUN 2
Comments
Patient Centricity & Pharma’s Reputation

The Two Faces of FDA Regarding the Opioid Epidemic

The #FDA has a lot of hurdles to overcome in its effort to stem the #opioid crisis it helped to create. And it doesn’t help that Trump’s proposed Medicaid cuts will negatively impact funding for drug rehab treatment.

3 MIN2017 MAY 26
Comments
The Two Faces of FDA Regarding the Opioid Epidemic

The Coming Digital Transformation of Pharma Marketing

Many pharmaceutical companies are operating well-established business processes that are not optimized for the digital era. This is leading to inefficiencies and missed opportunities. Arno Sosna, General Manager of Commercial Products at Veeva , describes efforts that are underway to overcome these inefficiencies and improve communications with physicians.

7 MIN2017 MAY 19
Comments
The Coming Digital Transformation of Pharma Marketing

Big Pharma Struggles to Distance Itself from “Price Gouging” Small Pharma

The drug industry is reeling from criticism about drug prices coming from all sides and especially from the president of the United States. First it tried public relations and CEO speaking tours. When that didn’t work it took more drastic actions

4 MIN2017 MAY 12
Comments
Big Pharma Struggles to Distance Itself from “Price Gouging” Small Pharma

The Benefits and Risks of Limiting Pharma Sales Rep Access to Physicians

Pharmaceutical sales representatives are faced with increasingly limited access to physicians as many academic medical centers and other healthcare centers adopt conflict of interest policies restricting detailing. This is another benefit versus risk challenge for physicians who need quick access to the latest information about novel drugs.

6 MIN2017 MAY 4
Comments
The Benefits and Risks of Limiting Pharma Sales Rep Access to Physicians

The Digital Gap Between Pharma and Other Industries

Brain Fox, Senior Partner at McKinsey, talks about how the pharma industry lags other industries in its investment in digital technology and in testing the effectiveness of its digital marketing campaigns.

1 MIN2017 APR 28
Comments
The Digital Gap Between Pharma and Other Industries

Latest Episodes

The Misleading Marketing of "Low-T" Drugs

A conversation with Adriane Fugh-Berman, MD, Associate Professor at Georgetown University Medical Center and Director of PharmedOut. We discuss how the marketing of Androgel uses symptom quizzes to convince men and physicians that "low testosterone" is a medical condition that should be treated. We also discuss the dangerous side effects of testosterone treatment and the similarities with estrogen treatment side effects, which took 20 years to unveil.

5 MIN2017 JUL 25
Comments
The Misleading Marketing of "Low-T" Drugs

The Forgotten eHealth Code of Ethics

Any research or effort designed to improve the quality of health information on the Internet must build upon the work already done by the creators of the international eHealth Code of Ethics, which is as relevant today as it was back in 2000.

4 MIN2017 JUN 23
Comments
The Forgotten eHealth Code of Ethics

AMA Struggles to Reign in Consumer Drug Ads

You have to give kudos to the good doctors and policy makers of the American Medical Association for trying over the course of many to ban or in some way curtail direct-to-consumer drug ads by pharmaceutical companies. The latest effort focuses on drug price transparency in ads. Will it succeed where the other efforts have failed?

4 MIN2017 JUN 16
Comments
AMA Struggles to Reign in Consumer Drug Ads

Counter Detailing Offers Redemption But Little Hope of Success

Do you hate your job in pharma? Perhaps, like a friend of mine, your position got eliminated after many years of loyal service. But it may be a blessing in disguise if the behavior of Big Pharma is more and more at odds with your personal values. If so, you have options for cleansing your soul.

4 MIN2017 JUN 13
Comments
Counter Detailing Offers Redemption But Little Hope of Success

Patient Centricity & Pharma’s Reputation

Patient Centricity used to be a buzzword in that it was often mentioned but seldom practiced by pharma companies. A lot of progress has been made in the past years to achieve patient centricity, but not all drug companies have had much success. Unfortunately, that has had a negative impact on the industry’s reputation

3 MIN2017 JUN 2
Comments
Patient Centricity & Pharma’s Reputation

The Two Faces of FDA Regarding the Opioid Epidemic

The #FDA has a lot of hurdles to overcome in its effort to stem the #opioid crisis it helped to create. And it doesn’t help that Trump’s proposed Medicaid cuts will negatively impact funding for drug rehab treatment.

3 MIN2017 MAY 26
Comments
The Two Faces of FDA Regarding the Opioid Epidemic

The Coming Digital Transformation of Pharma Marketing

Many pharmaceutical companies are operating well-established business processes that are not optimized for the digital era. This is leading to inefficiencies and missed opportunities. Arno Sosna, General Manager of Commercial Products at Veeva , describes efforts that are underway to overcome these inefficiencies and improve communications with physicians.

7 MIN2017 MAY 19
Comments
The Coming Digital Transformation of Pharma Marketing

Big Pharma Struggles to Distance Itself from “Price Gouging” Small Pharma

The drug industry is reeling from criticism about drug prices coming from all sides and especially from the president of the United States. First it tried public relations and CEO speaking tours. When that didn’t work it took more drastic actions

4 MIN2017 MAY 12
Comments
Big Pharma Struggles to Distance Itself from “Price Gouging” Small Pharma

The Benefits and Risks of Limiting Pharma Sales Rep Access to Physicians

Pharmaceutical sales representatives are faced with increasingly limited access to physicians as many academic medical centers and other healthcare centers adopt conflict of interest policies restricting detailing. This is another benefit versus risk challenge for physicians who need quick access to the latest information about novel drugs.

6 MIN2017 MAY 4
Comments
The Benefits and Risks of Limiting Pharma Sales Rep Access to Physicians

The Digital Gap Between Pharma and Other Industries

Brain Fox, Senior Partner at McKinsey, talks about how the pharma industry lags other industries in its investment in digital technology and in testing the effectiveness of its digital marketing campaigns.

1 MIN2017 APR 28
Comments
The Digital Gap Between Pharma and Other Industries
hmly
himalayaプレミアムへようこそ聴き放題のオーディオブックをお楽しみください。